The Johnson Investment Counsel Inc. Has $740,000 Position in Baxter International Inc. (BAX)

The Johnson Investment Counsel Inc. Has $740,000 Position in Baxter International Inc. (BAX)

Johnson Investment Counsel Inc. increased its position in shares of Baxter International Inc. (NYSE:BAX) by 3.0% during the third quarter, Holdings Channel reports. The institutional investor owned 15,556 shares of the company’s stock after buying an additional 453 shares during the period. Johnson Investment Counsel Inc.’s holdings in Baxter International were worth $740,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Stillwater Investment Management LLC increased its position in shares of Baxter International by 3.0% in the third quarter. Stillwater Investment Management LLC now owns 19,967 shares of the company’s stock worth $950,000 after buying an additional 588 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Baxter International by 3.5% in the third quarter. Bank of New York Mellon Corp now owns 5,726,864 shares of the company’s stock worth $272,597,000 after buying an additional 196,100 shares in the last quarter. California State Teachers Retirement System increased its position in shares of Baxter International by 0.8% in the third quarter. California State Teachers Retirement System now owns 1,093,450 shares of the company’s stock worth $52,048,000 after buying an additional 9,200 shares in the last quarter. Rhumbline Advisers increased its position in shares of Baxter International by 1.0% in the third quarter. Rhumbline Advisers now owns 741,111 shares of the company’s stock worth $35,277,000 after buying an additional 7,247 shares in the last quarter. Finally, Meag Munich Ergo Kapitalanlagegesellschaft MBH increased its position in shares of Baxter International by 6,732.0% in the third quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 539,731 shares of the company’s stock worth $25,343,000 after buying an additional 531,831 shares in the last quarter. Institutional investors and hedge funds own 82.68% of the company’s stock.

Shares of Baxter International Inc. (NYSE:BAX) traded down 0.43% during trading on Thursday, hitting $46.57. The stock had a trading volume of 1,928,488 shares. Baxter International Inc. has a 12-month low of $34.57 and a 12-month high of $50.16. The stock’s 50-day moving average is $44.90 and its 200-day moving average is $46.65. The stock has a market cap of $25.33 billion, a price-to-earnings ratio of 5.21 and a beta of 0.82.

Baxter International (NYSE:BAX) last posted its earnings results on Tuesday, October 25th. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.45 by $0.11. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.67 billion. Baxter International had a return on equity of 11.43% and a net margin of 48.68%. Baxter International’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.41 earnings per share. On average, equities research analysts expect that Baxter International Inc. will post $1.91 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, January 3rd. Investors of record on Friday, December 2nd were issued a $0.13 dividend. This represents a $0.52 annualized dividend and a yield of 1.12%. The ex-dividend date was Wednesday, November 30th. Baxter International’s dividend payout ratio (DPR) is presently 5.83%.

Several research analysts recently weighed in on BAX shares. Zacks Investment Research downgraded Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, October 17th. Evercore ISI restated a “buy” rating and set a $56.00 target price (up from $52.00) on shares of Baxter International in a research note on Wednesday, October 26th. Wells Fargo & Co. started coverage on Baxter International in a research note on Thursday, October 13th. They set an “outperform” rating on the stock. Royal Bank Of Canada boosted their target price on Baxter International from $50.00 to $55.00 and gave the stock a “sector perform” rating in a research note on Wednesday, October 26th. Finally, RBC Capital Markets restated a “sector perform” rating and set a $55.00 target price (up from $50.00) on shares of Baxter International in a research note on Wednesday, October 26th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the stock. Baxter International currently has an average rating of “Hold” and a consensus target price of $51.30.

About Baxter International

Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX).

Related posts

Leave a Comment